)
)
)
In the beginning there was a vision to improve and modernise immunodiagnostics. Scientists - like our founders, Dr. Christian Harwanegg and Dr. Christian Sascha Dennstedt - always strive for disruptive innovation. So after more than a decade with leading companies in the field Dr. Christian Harwanegg decided to start his own enterprise in 2016. The goal was clear: The newly founded company MADx (Macro Array Diagnostics) should create an allergy test that is supposed to be better, more efficient and easier to use than the ones of the competition. In addition, we wanted to offer the entire value chain from test material to evaluation and interpretation of results, all under one roof.
At our modern location in Vienna, we develop, test and research on more than 3600 square meters every day for the benefit of our patients. We are a multidisciplinary team of experts from a wide range of disciplines and combine years of top international experience in the field of in vitro diagnostics. Currently, the ever-growing MADx team consists of more than 100 employees, including experienced specialists from the fields of research, development, production, engineering, marketing, product management, people & culture, sales and finance.
)
Without question, but worth the effort: for sure. Over the past years, we have launched two generations of the ALEX (Allergy Xplorer), which now tests for around 300 different allergens - in a single, non-invasive step. Our panel covers nearly 100% of the world's relevant allergens. We have developed proprietary hardware and software solutions that define new standards. We are constantly innovating and expanding our portfolio, as most recently with the FOX (Food Xplorer), a solution for the detection of IgG-mediated food intolerances.
As scientists, we develop forward-thinking, intuitive immunodiagnostic solutions at the molecular level, setting a new gold standard in allergy and food intolerance diagnostics.
With an unwavering commitment to individual patient care and the highest quality standards, we propel personalised medicine forward and ensure outstanding diagnostic precision.
MADx revolutionises allergy and food intolerance diagnostics and is the first choice for clinicians, laboratories, and healthcare systems worldwide.
Our technology ensures precise and comprehensive results, accelerates scientific progress, and thus significantly contributes to the improvement of the quality of life for humans and animals.
The MADx processing systems are connected to our cloud-based software solution in real time. Data can be analysed and managed 24/7.
MADx offers the widest panel of molecular allergens (178) on one array. This is unique to our allergy test and increases the specificity compared to the exclusive use of allergen extracs.
One blood sample is enough to cover 300 different allergens and deliver one comprehensive result, making it a quick and reliable solution for both doctors and patients.
MADx works with distribution partners from over 80 countries around the world. Curious what they have to say about working with us? Watch the video and find out!
)
The quality of MADx products and services defines the relationship with our customers. Of course, we also see the high-quality training of our employees and their continuous further training in their specialist field as the basis of our success and customer loyalty.
Compliance with all official and legal requirements also plays a key role, which we ensure through effective, company-wide quality management.
MADx works on the basis of the internationally recognised and certified quality management systems EN ISO 13485 and EN ISO 9001 with defined standards, tested raw materials, components and services.
)
We develop, manufacture, and distribute products for immunological diseases. We thrive for leadership in innovation and market share in our industry. Our customers rely on our products, service and supply, and our goal is to not just meet their expectations, but to exceed them.
We are committed to continuously improve our quality system. Our quality policy provides the framework for setting companywide quality objectives, as well as their systematic evaluation. Thereby we ensure operational excellence, process and product improvement as well as global regulatory compliance.
We enable our team to grow with us by providing constant education, equal opportunities, best in class work environment, and fair leadership.
)
Every year, particularly innovative and international companies are awarded the title "Born Global Champions" by the WKO and AUSSENWIRTSCHAFT AUSTRIA. This honour was also bestowed on MADx in 2021.
Companies that are considered "Born Global Champions" are characterised by novel product ideas and a strong focus on international markets. Thus, they make an important contribution to the Austrian export economy at a very early stage of their existence.
With a unique and revolutionary product range and a steadily growing field of activity in over 70 countries worldwide, our company is the perfect candidate for the title of "Born Global Champion" - and will remain so in the future.